ODI Pharma AB (ODI.ST)

SEK 2.68

(21.82%)

Inventory Summary of ODI Pharma AB

  • ODI Pharma AB's latest annual inventory in 2023 was - SEK , down -100.0% from previous year.
  • ODI Pharma AB's latest quarterly inventory in 2023 FY was - SEK , down -100.0% from previous quarter.
  • ODI Pharma AB reported annual inventory of 807.93 Thousand SEK in 2022, down -53.55% from previous year.
  • ODI Pharma AB reported annual inventory of 1.73 Million SEK in 2021, up 65.71% from previous year.
  • ODI Pharma AB reported quarterly inventory of 348.69 Thousand SEK for 2023 Q2, down -56.78% from previous quarter.
  • ODI Pharma AB reported quarterly inventory of - SEK for 2023 Q4, down -100.0% from previous quarter.

Annual Inventory Chart of ODI Pharma AB (2023 - 2018)

Historical Annual Inventory of ODI Pharma AB (2023 - 2018)

Year Inventory Inventory Growth
2023 - SEK -100.0%
2022 807.93 Thousand SEK -53.55%
2021 1.73 Million SEK 65.71%
2020 1.04 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%

Peer Inventory Comparison of ODI Pharma AB

Name Inventory Inventory Difference
AcuCort AB -1.09 Million SEK 100.0%
AlzeCure Pharma AB (publ) -2508.00 SEK 100.0%
BioGaia AB (publ) 181.2 Million SEK 100.0%
Enzymatica AB (publ) 11.49 Million SEK 100.0%
Enorama Pharma AB (publ) 4.29 Million SEK 100.0%
Gabather AB (publ) -1772.00 SEK 100.0%
Klaria Pharma Holding AB (publ.) - SEK NaN%
Moberg Pharma AB (publ) 7.11 Million SEK 100.0%
Nanexa AB (publ) 1.91 Million SEK 100.0%
Newbury Pharmaceuticals AB (publ) 4.99 Million SEK 100.0%
Orexo AB (publ) 42.4 Million SEK 100.0%
Probi AB (publ) 116.7 Million SEK 100.0%
Swedencare AB (publ) 398.1 Million SEK 100.0%
Swedish Orphan Biovitrum AB (publ) 3.87 Billion SEK 100.0%
Toleranzia AB -1.34 Million SEK 100.0%
Vivesto AB - SEK NaN%